Patent details

Basic Information

Publication number:

EP2676953

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP131771909

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

HEMIFUMARATE SALT OF 1-[4-[1-(4-CYCLOHEXYL-3 -TRIFLUOROMETHYL-BENZYLOXYIMINO)-ETHYL]-2-ETHYL-BENZYL]-AZETIDINE-3-CARBOXYLIC ACID FOR USE IN THE TREATMENT OF LYMPHOCYTE MEDIATED DISEASES

French Title of Invention:

SEL HÉMIFUMARATE D'ACIDE 1-[4-[1-(4-CYCLOHEXYL-3-TRIFLUOROMÉTHYL-BENZYLOXYIMINO)-ÉTHYL]-2-ÉTHYL-BENZYL]-AZÉTIDINE-3-CARBOXYLIQUE POUR UNE UTILISATION DANS LE TRAITEMENT DES MALADIES LIEES AUX LYMPHOCYTES

German Title of Invention:

HEMIFUMARATSALZ VON 1-[4-[1-(4-CYCLOHEXYL-3-TRIFLUORMETHYLBENZYLOXYIMINO)-ETHYL]-2-ETHYLBENZYL]AZETIDIN-3-CARBONSÄURE ZUR BEHANDLUNG VON LYMPHOCYTENVERMITTELTEN KRANKHEITEN

SPC Number:

Dates

Filing date:

16/12/2009

Grant date:

22/03/2017

EP Publication Date:

25/12/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/03/2017

EP B1 Publication Date:

22/03/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

16/12/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/03/2017

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

Sschneeberger, Ricardo

Address:

Switzerland (CH)

2

Name:

De La Cruz, Marilyn

Address:

United States (US)

3

Name:

Riegert, Christian

Address:

Switzerland (CH)

4

Name:

Ciszewski, Lech

Address:

United States (US)

5

Name:

Karpinski, Piotr H.

Address:

United States (US)

6

Name:

Mutz, Michael

Address:

Switzerland (CH)

7

Name:

Vogel, Caspar

Address:

Switzerland (CH)

Priority

Priority Number:

203053 P

Priority Date:

18/12/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/397; A61P 35/00; A61P 37/00; C07D 205/04;

Publication

European Patent Bulletin

Issue number:

201712

Publication date:

22/03/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/12/2025

Annual Fee Number:

17

Annual Fee Amount:

246 Euro

Expected Payer:

Last Annual Fee Payment Date:

13/12/2024

Last Annual Fee Paid Number:

16

Last Annual Fee Paid Amount:

230 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages